Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus
- 5 February 2001
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 164 (1) , 105-110
- https://doi.org/10.1016/s0304-3835(00)00722-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: Report of a prospective trialInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Predictors of Distant Recurrence in Clinical Stage I or II Endometrial Carcinoma Treated by Combination Surgical and Radiation TherapyGynecologic Oncology, 1997
- The clinical significance of malignant peritoneal cytology in stage I endometrial carcinomaInternational Journal of Gynecologic Cancer, 1992
- Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine diseaseGynecologic Oncology, 1992
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991
- Prognostic value of peritoneal cytology in endometrial carcinomaGynecologic Oncology, 1990
- FIGO NewsInternational Journal of Gynecology & Obstetrics, 1989
- Prognostic significance of positive peritoneal cytology in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1988
- Risk factors and recurrent patterns in Stage I endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1985
- The prognostic value of peritoneal cytology in gynecologic malignant diseaseAmerican Journal of Obstetrics and Gynecology, 1971